“Open Pharma Members, Supporters and key Advisers came together to discuss the ways in which the scientific publishing community can make research accessible, discoverable and transparent for patients and the public.
Many organizations are working towards the same goals in terms of transparency, discoverability, accessibility and accountability in scientific publishing, but wouldn’t it be better if these goals were aligned? On 15 June 2020, Open Pharma brought together the different stakeholders in academic publishing for a virtual roundtable meeting with the aim of coordinating their approach to open access models and enhanced content for scientific publications. Following a recap of the January roundtable meeting, attendees discussed the benefits of open access mandates for pharma. A clear definition of what open access is, with regards to Creative Commons licences and publishing embargoes, and a strong communications plan were both shown to be key to the successful implementation of a mandatory open access policy….”